US Patent Issued to Vanderbilt University on June 23 for "Methods of treating anti-NMDAR-associated neuropsychiatric disorders" (Tennessee Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,328, issued on June 23, was assigned to Vanderbilt University (Nashville, Tenn.).

"Methods of treating anti-NMDAR-associated neuropsychiatric disorders" was invented by Jill M. Pulley (Nashville, Tenn.) and Jillian P. Rhoads (Nashville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to methods for treating a neuropsychiatric disorder associated with expression of autoantibodies to ionotropic glutamate receptor, NMD A 2A (GiuN2A), expression of anti-double-stranded (ds) DNA antibodies that cross react with one or more subunits of the NMD A receptor, or a mutation in the ionotropic glutamate receptor NMD A type...